338 related articles for article (PubMed ID: 18071953)
1. Intracellular antibodies (intrabodies) and their therapeutic potential.
Lo AS; Zhu Q; Marasco WA
Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
[TBL] [Abstract][Full Text] [Related]
2. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
Heng BC; Cao T
Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
[TBL] [Abstract][Full Text] [Related]
3. Intrabodies: turning the humoral immune system outside in for intracellular immunization.
Marasco WA
Gene Ther; 1997 Jan; 4(1):11-5. PubMed ID: 9068790
[TBL] [Abstract][Full Text] [Related]
4. Intrabody applications in neurological disorders: progress and future prospects.
Miller TW; Messer A
Mol Ther; 2005 Sep; 12(3):394-401. PubMed ID: 15964243
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic expression and specific binding of the VH/VL single domain intrabodies in transfected NIH3T3 cells.
Sawahata R; Sato M; Kitani H
Exp Mol Pathol; 2009 Feb; 86(1):51-6. PubMed ID: 19094983
[TBL] [Abstract][Full Text] [Related]
6. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
7. Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo.
Chartier A; Raz V; Sterrenburg E; Verrips CT; van der Maarel SM; Simonelig M
Hum Mol Genet; 2009 May; 18(10):1849-59. PubMed ID: 19258344
[TBL] [Abstract][Full Text] [Related]
8. [Intrabodies, potent tools to unravel the function and dynamics of intracellular proteins].
Moutel S; Perez F
Med Sci (Paris); 2009 Dec; 25(12):1173-6. PubMed ID: 20035701
[TBL] [Abstract][Full Text] [Related]
9. Enhanced intracellular stability of sFv-Fc fusion intrabodies.
Strube RW; Chen SY
Methods; 2004 Oct; 34(2):179-83. PubMed ID: 15312671
[TBL] [Abstract][Full Text] [Related]
10. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
[TBL] [Abstract][Full Text] [Related]
11. The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases.
Cardinale A; Biocca S
Trends Mol Med; 2008 Sep; 14(9):373-80. PubMed ID: 18693139
[TBL] [Abstract][Full Text] [Related]
12. Rapid isolation of intrabody candidates by using an optimized non-immune phage antibody library.
Nagano K; Imai S; Mukai Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
Pharmazie; 2009 Apr; 64(4):238-41. PubMed ID: 19435141
[TBL] [Abstract][Full Text] [Related]
13. Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications.
Cao T; Heng BC
Ann Clin Lab Sci; 2005; 35(3):227-9. PubMed ID: 16081577
[TBL] [Abstract][Full Text] [Related]
14. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
15. A protein silencing switch by ligand-induced proteasome-targeting intrabodies.
Melchionna T; Cattaneo A
J Mol Biol; 2007 Nov; 374(3):641-54. PubMed ID: 17950312
[TBL] [Abstract][Full Text] [Related]
16. [New type recombinant antibody fragment scFv multimer and cancer targeting].
Guo J; Cai M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):361-5. PubMed ID: 12856620
[TBL] [Abstract][Full Text] [Related]
17. Generation of functional scFv intrabodies for triggering anti-tumor immunity.
Bonnin E; Gruel N; Moutel S; Mantegazza AR; Barrio MM; Mordoh J; Teillaud JL
Methods; 2004 Oct; 34(2):225-32. PubMed ID: 15312675
[TBL] [Abstract][Full Text] [Related]
18. Antigen-independent selection of intracellular stable antibody frameworks.
Auf der Maur A; Tissot K; Barberis A
Methods; 2004 Oct; 34(2):215-24. PubMed ID: 15312674
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances with ER Targeted Intrabodies.
Marschall AL; Dübel S; Böldicke T
Adv Exp Med Biol; 2016; 917():77-93. PubMed ID: 27236553
[TBL] [Abstract][Full Text] [Related]
20. Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells.
Sibler AP; Courtête J; Muller CD; Zeder-Lutz G; Weiss E
FEBS J; 2005 Jun; 272(11):2878-91. PubMed ID: 15943819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
